CLINICAL_TRIALS
trial_result
· 2017-12-28
Clinical Trial Update: BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 trial update of BI 1356 BS in Japanese patients with Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED